Insulin Resistance in Relation to Hyperthyroidism and Hypothyroidism
1 other identifier
observational
100
0 countries
N/A
Brief Summary
Insulin resistance and its relation to hyperthyrodism and Hypothyroidism
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 1, 2024
CompletedFirst Posted
Study publicly available on registry
May 6, 2024
CompletedStudy Start
First participant enrolled
June 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedMay 6, 2024
May 1, 2024
1 year
May 1, 2024
May 1, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
The prevalence of diabetes mellitus among patients with thyroid disorders
to prove the prevalence of diabetes mellitus is elevated among patients with thyroid disorders
baseline
Eligibility Criteria
Based on determining the main outcome variable, the estimated minimum required sample size is 108cases (36cases in each group ). The sample size was calculated using G\*power software 3.1.9.7., based on the following assumptions: HbA1C was elevated in 22.3% of hypothyroid group and 21% of hyperthyroid group compared to controls group eleveted only in ( 16.1%) Medium effect size was estimate to be 0.3 Main statistical test is chi\_squer test ,goodness of fit Alpha = 0.05, Power = 0.80 Allocation ratio= 1.
You may qualify if:
- Adult pations above 18 years old
You may not qualify if:
- Any patients with Diabetes mellitus
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (6)
Chubb SA, Davis WA, Davis TM. Interactions among thyroid function, insulin sensitivity, and serum lipid concentrations: the Fremantle diabetes study. J Clin Endocrinol Metab. 2005 Sep;90(9):5317-20. doi: 10.1210/jc.2005-0298. Epub 2005 Jun 28.
PMID: 15985488BACKGROUNDRaboudi N, Arem R, Jones RH, Chap Z, Pena J, Chou J, Field JB. Fasting and postabsorptive hepatic glucose and insulin metabolism in hyperthyroidism. Am J Physiol. 1989 Jan;256(1 Pt 1):E159-66. doi: 10.1152/ajpendo.1989.256.1.E159.
PMID: 2643338BACKGROUNDClement K, Viguerie N, Diehn M, Alizadeh A, Barbe P, Thalamas C, Storey JD, Brown PO, Barsh GS, Langin D. In vivo regulation of human skeletal muscle gene expression by thyroid hormone. Genome Res. 2002 Feb;12(2):281-91. doi: 10.1101/gr.207702.
PMID: 11827947BACKGROUNDSingh BM, Goswami B, Mallika V. Association between insulin resistance and hypothyroidism in females attending a tertiary care hospital. Indian J Clin Biochem. 2010 Apr;25(2):141-5. doi: 10.1007/s12291-010-0026-x. Epub 2010 May 27.
PMID: 23105900BACKGROUNDMari A, Ahren B, Pacini G. Assessment of insulin secretion in relation to insulin resistance. Curr Opin Clin Nutr Metab Care. 2005 Sep;8(5):529-33. doi: 10.1097/01.mco.0000171130.23441.59.
PMID: 16079624BACKGROUNDSanghvi A, Virji MA, Warty V, Dimasi MJ. Differential suppression of lymphocyte cholesterol synthesis by low density lipoprotein and erythrocyte insulin receptors in normolipidemic subjects. Atherosclerosis. 1983 Dec;49(3):307-18. doi: 10.1016/0021-9150(83)90141-7.
PMID: 6362680BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
May 1, 2024
First Posted
May 6, 2024
Study Start
June 1, 2024
Primary Completion
June 1, 2025
Study Completion
July 1, 2025
Last Updated
May 6, 2024
Record last verified: 2024-05